LTA II KIT Drug Patent Profile
✉ Email this page to a colleague
When do Lta Ii Kit patents expire, and when can generic versions of Lta Ii Kit launch?
Lta Ii Kit is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in LTA II KIT is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lta Ii Kit
A generic version of LTA II KIT was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18th, 1982.
US Patents and Regulatory Information for LTA II KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LTA II KIT | lidocaine hydrochloride | SOLUTION;TOPICAL | 080409-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | LTA II KIT | lidocaine hydrochloride | SOLUTION;TOPICAL | 088542-001 | Jul 31, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
